Blood pressure medications recalled over potential carcinogen

The decision of Health Canada to recall drugs over concerns the raw material contained a cancer causing impurity has left patients to question what they were potentially exposed to the carcinogenic. In July 2018, the agency ordered a recall of several variations of valsartan, a drug that had been regularly prescribed to address high blood pressure and prevent heart attacks and strokes. On March 9, 2019, manufacturers voluntarily expanded the recall to include a number of products containing losa